2015, Number S3
<< Back Next >>
Rev Mex Anest 2015; 38 (S3)
Hormonal dysfunction in the neurocritic patient
de la Cruz-López A, Garrido-Aguirre E
Language: Spanish
References: 7
Page: 441-442
PDF size: 114.59 Kb.
Text Extraction
No abstract.
REFERENCES
Kelly DF, Gonzalo IT, Cohan P, Berman N, Swerdloff R, Wang C. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage: a preliminary report. J Neurosurg. 2000;93:743-752.
Dimopoulou I, Tsagarakis S, Kouyialis AT, Roussou P, Assithianakis G, Christoforaki, et al. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels. Crit Care Med. 2004;32:404-408.
Savaridas T, Andrews PJ, Harris B. Cortisol dynamics following acute severe brain injury. Intensive Care Med. 2004;30:1479-1483.
Agha A, Phillips J, Thompson CJ. Hypopituitarism following traumatic brain injury (TBI). Br J Neurosurg. 2007;21:210-216.
Feigin VL, Anderson N, Rinkel GJ, Algra A, van Gijn J, Bennett DA. Corticosteroids for aneurysmal subarachnoid haemorrhage and primary intracerebral haemorrhage. Cochrane Database Syst Rev. 2005;CD004583.
Rabinstein AA, Bruder N. Management of hyponatremia and volume contraction. Cuidado Neurocrit. 2011;15:354-360.
Vespa P. Hormonal dysfunction in neurocritical patients. Curr Opin Crit Care. 2013;19:107-112.
Full text